| Application no. and date | 18718452.8 (espacenet) (Federated) (European Patent Register), 20180418 | | Patent/reg. no. and date | DK/EP 3612537, 20220713 | | Publication date | 20200226 | | Priority no. and date | GB 201706133, 20170418, GB 201721337, 20171219 | | EP pub. no. and date |
EP 3612537 20200226 | | Effective date | | | Applicant/owner | Medimmune Limited, Milstein Building Granta Park
Cambridge, Cambridgeshire CB21 6GH, GB | | Applicant ref. no. | V446943DK00 | | Inventor | HOWARD, Philip Wilson, C/O MedImmune Limited
Milstein Building
Granta Park
Cambridge
Cambridgeshire CB21 6GH, GB,
GREGSON, Stephen John, C/O MedImmune Limited
Milstein Building
Granta Park
Cambridge
Cambridgeshire CB21 6GH, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07D 519/00 (2006.01) , C07K 5/062 (2006.01) | | Title | PYRROLOBENZODIAZEPINKONJUGATER | | Int. application no. | EP2018059846 | | Int. publication no. | WO2018192944 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
